Article
Spotlight on retapamulin in impetigo and other uncomplicated superficial skin infections.
American journal of clinical dermatology - 1 Jan 2008
Yang Lily P H, Keam Susan J
Abstract excerpt
Topical retapamulin (Altabax, Altargo) is the first pleuromutilin antibacterial approved for the treatment of uncomplicated superficial skin infections caused by Staphylococcus aureus (excluding methicillin-resistant S. aureus [MRSA]) and Streptococcus pyogenes in patients aged > or = 9 months. In the EU, retapamulin is indicated for use in patients with impetigo or with infected small lacerations, abrasions, or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
